89bio(ETNB)

搜索文档
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)
Globenewswire· 2025-10-08 23:22
BALA CYNWYD, Pa., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. 89bio, Inc. (Nasdaq - ETNB) Under the terms of the Merger Agreement, 89bio will be acquired by Roche (SIX: RO, ROG; OTCQX: RHHBY) for $14.50 per share in cash, plus a non-tra ...
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash
Globenewswire· 2025-10-02 04:30
Basel, 1 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has commenced a tender offer for all of the outstanding shares of common stock of 89bio, Inc. (89bio) (NASDAQ: ETNB) at a price of $14.50 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain milestone payments of up to an aggregate of $6.00 per share in cash. The tender offer is being made pursuant to the previously announced merger agreement dated as of September 17, 2025, among Roche Holdi ...
89bio, Inc. (ETNB) Shareholders to Receive Up to $3.5B Total in Roche Buyout Deal
Yahoo Finance· 2025-10-01 00:34
We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. 89bio, Inc. is one of them. 89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardiometabolic diseases, particularly metabolic dysfunction-associated steatohepatitis (MASH). Its lead candidate, pegozafermin, is a long-acting FGF21 analog designed to treat moderate to severe MASH, including advanced fibrosis, as well as related metabolic disorders. In ...
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)
Prnewswire· 2025-09-24 05:30
Accessibility StatementSkip Navigation NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating 89bio, Inc. (NASDAQ: ETNB) related to its sale to Roche Holdings, Inc. Under the terms of ...
3 Potential Biotech Acquisition Targets
Seeking Alpha· 2025-09-20 00:53
Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .Last week, Seeking Alpha posted some takes on potential buyouts in the biotech/biopharma sector. Thursday morning, Roche ( OTCQX:RHHBY ) announced it was acquiring 89bio, Inc ( ETNB ) in a deal that could reach $3.5 billion, which inclu ...
89BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 89bio, Inc. - ETNB
Businesswire· 2025-09-20 00:24
收购交易结构 - 罗氏控股公司拟以每股14.50美元现金收购89bio公司全部股份 [1] - 交易额外包含每股最高6美元的非交易型或有价值权利支付 [1] - 总对价包含现金与或有支付两部分构成 [1] 交易调查动态 - 前路易斯安那州总检察长联合KSF律师事务所对收购案展开调查 [1] - 调查针对罗氏控股公司与89bio公司之间的交易条款 [1] - 调查主体为纳斯达克上市公司89bio(代码:ETNB)与场外交易市场罗氏(代码:RHHBY) [1]
89Bio (ETNB) Soars 86 Percent to Historic High on $3.5-Billion Roche Merger
Yahoo Finance· 2025-09-19 20:46
We recently published 10 Stocks Stole the Show, 5 Hit Historic Highs. 89bio Inc. (NASDAQ:ETNB) is one of the best performers on Thursday. Shares of 89bio surged to a fresh record high on Thursday as investor funds poured into its stock following announcements that it was set to be acquired by Swiss company Roche for $3.5 billion. At intra-day trading, 89bio Inc. (NASDAQ:ETNB) soared by as much as 86 percent to its highest 52-week price of $15.06, before trimming gains to end the day just up by 85.15 perc ...
This United Parcel Service Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL)
Benzinga· 2025-09-19 20:06
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.BMO Capital analyst Fadi Chamoun downgraded United Parcel Service, Inc. UPS from Outperform to Market Perform and cut the price target from $125 to $96. United Parcel Service shares closed at $85.05 on Thursday. See how other analysts view this stock.HC Wainwright & Co. analyst Andrew S. Fein downgraded the r ...
U.S. Stock Market Today: Futures Mixed After Record Highs, Tech and Fed Policy in Focus
Stock Market News· 2025-09-19 18:07
市场整体表现与情绪 - 周五盘前美股期货表现不一,标普500期货一度上涨0.2%,但其他报告显示其下跌0.1%,纳斯达克100期货同样波动,显示市场在消化美联储降息后持谨慎态度[1][2] - 周四三大股指均创历史收盘新高,道琼斯工业平均指数上涨0.27%,标普500指数上涨0.48%,纳斯达克综合指数上涨0.94%,此轮上涨由科技股和网络安全股推动[3] - 10年期美国国债收益率上升2个基点至4.13%,2年期收益率上升1个基点至3.58%[2] 驱动市场的关键因素 - 美联储于周三决定降息25个基点,其点阵图显示的鸽派转向助长了市场对进一步降息的预期,提振了风险情绪[3] - 劳动力市场数据强于预期,截至9月13日当周的美国每周初请失业金人数降至23.1万,低于预期,缓解了投资者对经济放缓的担忧[3] - 英伟达宣布同意向英特尔投资50亿美元以共同开发用于个人电脑和数据中心的芯片,该消息推动英特尔股价周四大涨超过23%,英伟达股价上涨3.5%[7] 即将到来的关键事件与数据 - 未来几天将发布的重要经济数据包括9月22日当周的采购经理人指数初值,以及9月26日发布的美联储偏好通胀指标——美国核心个人消费支出价格指数[5] - 联邦公开市场委员会于9月17日发布了2025年至2028年的实际国内生产总值增长、失业率和通胀预期 projections[4] - 多家公司计划在9月19日发布季度财报,包括MoneyHero Limited、IperionX Limited ADR、Cantaloupe等[6] 个股表现与公司动态 - 联邦快递股价周四大涨5%,因其公布的第一财季业绩超预期,并预计2026财年营收增长4%-6%,每股收益 forecast 为17.20-19.00美元[11] - 89bio股价飙升85%,因罗氏同意以每股14.50美元的现金收购该公司,该交易前期价值为24亿美元,若包含或有价值权,总价值最高可达35亿美元[11] - 22nd Century Group股价大幅上涨31%,因公司宣布已偿还390万美元高级担保债务,实现无债务状态,并计划扩大极低尼古丁烟草叶库存以支持增产[11] - Red Cat Holdings股价下跌12%,因这家无人机技术公司以每股9.60美元的价格发行1560万股,旨在筹集约1.5亿美元资金[11] - 纽柯钢铁股价下跌4%,因公司指引第三季度每股收益为2.05-2.15美元,远低于市场普遍预期的2.56美元[11] - 服务器公司CoreWeave盘前股价上涨0.3%,此前Loop Capital以“买入”评级开始覆盖该股,分析师指出其在芯片巨头和人工智能实验室中的影响力日益增强[11]
Stock Indexes Rally to Record Highs on Fed Rate Cut Expectations
Nasdaq· 2025-09-19 06:38
主要股指表现 - 标普500指数上涨0.48% 纳斯达克100指数上涨0.95% 道琼斯工业指数上涨0.27% 三大指数均创历史新高[1][2] - 九月E-mini标普期货上涨0.50% E-mini纳斯达克期货上涨0.92%[1] 半导体行业动态 - 英特尔股价大涨超过22% 英伟达同意投资50亿美元并宣布将共同开发PC和数据中心芯片[2][12] - KLA Corp上涨超过6% ASML Holding NV上涨超过6% Applied Materials上涨超过6%[12] - 美光科技上涨超过5% Marvell Technology上涨超过5% ON Semiconductor上涨超过4%[12] - 英伟达股价上涨超过3% GlobalFoundries上涨超过2% NXP Semiconductors NV上涨超过2%[12] - ARM Holdings下跌超过4% 因英伟达投资英特尔的消息影响[17] 宏观经济数据 - 每周初请失业金人数下降33,000人至231,000人 低于预期的240,000人[5] - 九月费城联储商业展望调查上升23.5点至23.2 创8个月新高 远高于预期的1.7[5] - 八月领先指标下降0.5% 差于预期的下降0.2% 为四个月最大降幅[6] - 10年期国债收益率上升1.4个基点至4.101% 创两周新高[7] 个股表现 - CrowdStrike上涨超过12% 公司在投资者简报中讨论AI战略并给出2027财年初步展望[13] - 89bio上涨超过85% 罗氏宣布以35亿美元收购公司 每股收购价14.50美元[13] - AeroVironment上涨超过4% 美国银行首次覆盖给予买入评级 目标价300美元[13] - Allstate上涨超过4% 报告八月灾难损失1.68亿美元 环比下降8.7%[14] - Cooper Cos上涨超过4% 董事会批准增加10亿美元股票回购计划至20亿美元[14] - CSX Corp上涨超过2% RBC资本市场将评级从行业表现上调至跑赢大盘 目标价39美元[14] - FactSet Research Systems下跌超过10% 第四季度调整后EPS为4.05美元低于预期的4.15美元[15] - Red Cat下跌超过10% 宣布计划通过承销公开发行出售普通股[16] - Darden Restaurants下跌超过7% 预测2026年调整后EPS为10.50-10.70美元 中点低于预期的10.67美元[16] - Cracker Barrel下跌超过7% 预测2025年收入33.5-34.5亿美元 低于预期的35.2亿美元[17] - Nucor下跌超过5% 预测第三季度EPS为2.05-2.15美元 远低于预期的2.59美元[17] - Live Nation Entertainment下跌超过2% 遭美国联邦贸易委员会和七个州起诉[18] 央行政策与利率 - 市场定价显示94%概率美联储在10月28-29日FOMC会议上降息25个基点[6] - 英国央行以7-2投票维持官方银行利率在4.00%不变[11] - 掉期市场定价显示ECB在10月30日政策会议上降息25个基点的概率为2%[11] - 10年期德国国债收益率上升5.1个基点至2.726% 创两周新高[10] - 10年期英国国债收益率上升5.1个基点至4.676% 创1.5周新高[10] 国际市场表现 - 欧洲斯托克50指数上涨1.62% 创3.5周新高[6] - 中国上证综指下跌1.15% 从10年高点回落[6] - 日经225指数上涨1.15% 创历史新高[6]